The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HSTC | +35.62% | +1,006.15% | +61.59% | -99% |
| S&P | +14.43% | +77.25% | +12.13% | +395% |
HST Global, Inc. is a health and wellness biotechnology company, which engages in the acquisition of a network of wellness centers that are focused on the homeopathic and alternative treatments of late-stage cancer. The company was founded on April 11, 1984 and is headquartered in Hampton, VA.
No news articles found for Hst Global.
| Q4 2024 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | -$38.06K | 0.0% |
| Market Cap | $36.36M | 0.0% |
| Net Income | -$148.02K | 0.0% |
| EBITDA | -$109.96K | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2024 | YOY Change | |
|---|---|---|
| Net Cash | $28.80K | 0.0% |
| Inventory | 0 | 0.0% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Long Term Debt | $270.32K | 0.0% |
| Short Term Debt | $338.98K | 0.0% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -6.87% | 0.0% |
| Return On Invested Capital | -2438.57% | 0.0% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$94.06K | 0.0% |
| Operating Free Cash Flow | -$94.06K | 0.0% |
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -7.53 | -8.21 | -2418.60 | 29.34 | - |
| Price to Tangible Book Value | -7.54 | -8.21 | -2417.57 | -1147.95 | - |
| Enterprise Value to EBITDA | -139.52 | -1893.78 | -3192.94 | -374.56 | - |
| Return on Equity | -29.7% | -8.5% | - | ||
| Total Debt | $100.32K | $21.60K | $41.60K | $609.30K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
